These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21050244)

  • 1. Effect of oral zinc in hepatic encephalopathy remains unclear.
    Coughlan J; Hamlin PJ; Ford AC
    Aliment Pharmacol Ther; 2010 Dec; 32(11-12):1405-6; author reply 1406-7. PubMed ID: 21050244
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial: oral zinc in hepatic encephalopathy.
    Takuma Y; Nouso K; Makino Y; Hayashi M; Takahashi H
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1080-90. PubMed ID: 20822500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of acute portosystemic encephalopathy with zinc].
    Couinaud C
    Chirurgie; 1985; 111(7):575-9. PubMed ID: 3830608
    [No Abstract]   [Full Text] [Related]  

  • 4. L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis.
    Jiang Q; Jiang XH; Zheng MH; Chen YP
    J Gastroenterol Hepatol; 2009 Jan; 24(1):9-14. PubMed ID: 18823442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone in the management of hepatic encephalopathy.
    Jiang Q; Jiang G; Welty TE; Zheng M
    J Clin Pharm Ther; 2010 Jun; 35(3):333-41. PubMed ID: 20831534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ornithine aspartate in hepatic encephalopathy: an established new therapeutic approach. Overview and results of current randomized studies].
    Krüger B; Held C; Kircheis G
    Z Arztl Fortbild (Jena); 1994 Sep; 88(9):673-9. PubMed ID: 7975752
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G; Parisi G; Banti S
    Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

  • 9. A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy.
    Chavez-Tapia NC; Cesar-Arce A; Barrientos-Gutiérrez T; Villegas-López FA; Méndez-Sanchez N; Uribe M
    Nutr J; 2013 Jun; 12():74. PubMed ID: 23742732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics in the management of hepatic encephalopathy: an evidence-based review.
    Rothenberg ME; Keeffe EB
    Rev Gastroenterol Disord; 2005; 5 Suppl 3():26-35. PubMed ID: 17713457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of portal systemic encephalopathy: standard and new treatments.
    Marín E; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of zinc salts lozenges and the common cold.
    Jackson JL; Peterson C; Lesho E
    Arch Intern Med; 1997 Nov; 157(20):2373-6. PubMed ID: 9361579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of zinc deficiency on effectiveness of the treatment of liver encephalopathy in patients with liver cirrhoses].
    Shaposhnikova NA; Drozdov VN; Petrakov AV; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2007; (5):46-50, 164. PubMed ID: 18389597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids.
    Chalasani N; Gitlin N
    Am J Gastroenterol; 1996 Jun; 91(6):1266-8. PubMed ID: 8651189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P; Grimm G
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis].
    Shuliat'ev IS; Il'chenko LIu; Vinnitskaia EV; Petrakov AV; Sil'verstrova SIu
    Eksp Klin Gastroenterol; 2002; (5):38-41, 127. PubMed ID: 12619575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal hepatic encephalopathy: time to recognise and treat.
    Dhiman RK; Chawla YK
    Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hepatic encephalopathy with oral branched-chain amino acids: I. Acute hepatic encephalopathy].
    Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
    Rev Esp Enferm Apar Dig; 1987 Aug; 72(2):116-22. PubMed ID: 3659529
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of L-dopa on hepatic coma].
    Jorge AD; Sanchez D
    Schweiz Rundsch Med Prax; 1973 Jul; 62(27):868-72. PubMed ID: 4578027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.